688289 圣湘生物
交易中 07-01 10:25:42
资讯
新帖
简况
圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%
证券之星 · 06-30 17:58
圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%
每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%
证券之星 · 06-28
每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%
圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%
证券之星 · 06-26
圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%
证券之星 · 06-25
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%
圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%
证券之星 · 06-23
圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%
圣湘生物(688289.SH)拟5000万元至1亿元回购股份
智通财经 · 06-23
圣湘生物(688289.SH)拟5000万元至1亿元回购股份
圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证
证券之星 · 06-23
圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证
股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股
证券之星 · 06-23
股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股
圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%
证券之星 · 06-22
圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%
每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行
证券之星 · 06-20
每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%
证券之星 · 06-18
圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%
股市必读:圣湘生物(688289)6月16日董秘有最新回复
证券之星 · 06-17
股市必读:圣湘生物(688289)6月16日董秘有最新回复
每周股票复盘:圣湘生物(688289)调整利润分配现金分红总额
证券之星 · 06-07
每周股票复盘:圣湘生物(688289)调整利润分配现金分红总额
圣湘生物最新公告:拟与关联方共同增资圣微速敏
证券之星 · 06-04
圣湘生物最新公告:拟与关联方共同增资圣微速敏
圣湘生物最新公告:董事长戴立忠提议以5000万元-1亿元回购公司股份
证券之星 · 06-04
圣湘生物最新公告:董事长戴立忠提议以5000万元-1亿元回购公司股份
圣湘生物(688289)披露2023年限制性股票激励计划第二个归属期归属结果公告,6月1日股价上涨0.98%
证券之星 · 06-01
圣湘生物(688289)披露2023年限制性股票激励计划第二个归属期归属结果公告,6月1日股价上涨0.98%
每周股票复盘:圣湘生物(688289)2025年度股东会多项议案获通过
证券之星 · 05-24
每周股票复盘:圣湘生物(688289)2025年度股东会多项议案获通过
圣湘生物(688289)披露2025年年度股东会法律意见书,5月20日股价上涨0.97%
证券之星 · 05-20
圣湘生物(688289)披露2025年年度股东会法律意见书,5月20日股价上涨0.97%
圣湘生物(688289)披露2025年年度股东会会议资料,5月13日股价下跌0.93%
证券之星 · 05-13
圣湘生物(688289)披露2025年年度股东会会议资料,5月13日股价下跌0.93%
圣湘生物涨5.19%,华源证券二日前给出“买入”评级
证券之星 · 05-11
圣湘生物涨5.19%,华源证券二日前给出“买入”评级
加载更多
公司概况
公司名称:
圣湘生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-28
主营业务:
圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。
发行价格:
50.48
{"stockData":{"symbol":"688289","market":"SH","secType":"STK","nameCN":"圣湘生物","latestPrice":14.43,"timestamp":1782872742000,"preClose":14.4,"halted":0,"volume":2188216,"delay":0,"changeRate":0.0021,"floatShares":579000000,"shares":579000000,"eps":0.2709,"marketStatus":"交易中","change":0.03,"latestTime":"07-01 10:25:42","open":14.32,"high":14.51,"low":14.21,"amount":31421900,"amplitude":0.0208,"askPrice":14.44,"askSize":178,"bidPrice":14.43,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.2709,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1782876600000},"marketStatusCode":2,"adr":0,"adjPreClose":14.4,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":15.84,"lowLimit":12.96,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":579388006,"isCdr":false,"pbRate":1.16,"roa":"--","peRate":53.266888,"roe":"0.69%","epsLYR":0.34,"committee":0.308943,"marketValue":8361000000,"turnoverRate":0.0038,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-07-02。","floatMarketCap":8361000000},"requestUrl":"/m/hq/s/688289","defaultTab":"news","newsList":[{"id":"2647534415","title":"圣湘生物(688289)披露与专业机构共同投资设立基金暨关联交易进展,6月30日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647534415?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:58","pubTimestamp":1782813528,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘,圣湘生物报收于14.4元,较前一交易日下跌2.04%,最新总市值为83.43亿元。该股当日开盘14.7元,最高14.73元,最低14.27元,成交额达7158.86万元,换手率为0.86%。圣湘生物科技股份有限公司于近日发布《关于与专业机构共同投资设立基金暨关联交易的进展公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313137","title":"每周股票复盘:圣湘生物(688289)股东陈文义持股降至4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313137","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646313137?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:24","pubTimestamp":1782584652,"startTime":"0","endTime":"0","summary":"本周关注点股本股东变化:股东陈文义因司法强制执行,持股比例由5.56%降至4.56%。股本股东变化股东增减持6月22日,圣湘生物股东陈文义在2026年3月17日至6月22日期间合计减持142.79万股,占总股本0.2464%,期间股价下跌26.68%,截至6月22日收盘价为13.88元。执行完成后,持股数量由30,397,386股减少至26,427,386股,持股比例由5.25%下降至4.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646135549","title":"圣湘生物(688289)披露以集中竞价交易方式首次回购公司股份的公告,6月26日股价上涨1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646135549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646135549?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:51","pubTimestamp":1782467489,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,圣湘生物报收于14.12元,较前一交易日上涨1.8%,最新总市值为81.81亿元。该股当日开盘13.87元,最高14.73元,最低13.79元,成交额达1.3亿元,换手率为1.57%。圣湘生物科技股份有限公司于2026年6月26日披露《关于以集中竞价交易方式首次回购公司股份的公告》。回购股份拟用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646269876","title":"圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果公告,6月25日股价下跌2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646269876","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646269876?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:37","pubTimestamp":1782380257,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘,圣湘生物报收于13.87元,较前一交易日下跌2.8%,最新总市值为80.36亿元。该股当日开盘14.16元,最高14.2元,最低13.68元,成交额达7232.53万元,换手率为0.9%。圣湘生物科技股份有限公司于近日发布公告,披露持股5%以上股东陈文义先生因债务履行需求,其所持公司股份被法院依法强制执行。执行完成后,陈文义先生持股由30,397,386股减少至26,427,386股,持股比例由5.25%下降至4.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500032269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645383270","title":"圣湘生物(688289)披露变更部分回购股份用途并注销暨减少注册资本的公告,6月23日股价上涨2.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645383270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645383270?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:33","pubTimestamp":1782225196,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘,圣湘生物报收于14.17元,较前一交易日上涨2.09%,最新总市值为82.1亿元。近日,圣湘生物科技股份有限公司发布《关于变更部分回购股份用途并注销暨减少注册资本的公告》。公告显示,公司拟将存放于回购专用证券账户中原用于员工持股计划或股权激励的4,450,202股股份予以注销,减少注册资本。本次变更部分回购股份用途并注销不会对公司经营和财务状况产生重大影响,不影响公司上市条件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645835254","title":"圣湘生物(688289.SH)拟5000万元至1亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2645835254","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645835254?lang=zh_cn&edition=full","pubTime":"2026-06-23 20:01","pubTimestamp":1782216083,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣湘生物(688289.SH)发布公告,公司拟5000万元至1亿元回购股份,回购价格不超过22元/股,回购的股份将在未来适宜时机全部用于员工持股计划或股权激励。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645915833","title":"圣湘生物最新公告:肺炎克雷伯菌及KPC基因检测试剂盒获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2645915833","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645915833?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:20","pubTimestamp":1782213602,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司产品肺炎克雷伯菌及耐碳青霉烯类抗生素基因KPC核酸检测试剂盒(荧光PCR法)近日获国家药监局颁发的《医疗器械注册证》,用于体外定性检测人痰液样本中的肺炎克雷伯菌核酸及KPC耐药基因。该产品系公司第二款“病原+耐药”双覆盖产品,进一步完善了呼吸道感染精准诊断领域布局。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300036573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","688289","BK1574","09996","159883","BK0239","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645071784","title":"股市必读:XD圣湘生(688289)6月22日圣湘生物发布公告,股东减持142.79万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645071784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645071784?lang=zh_cn&edition=full","pubTime":"2026-06-23 01:56","pubTimestamp":1782150971,"startTime":"0","endTime":"0","summary":"股本股东变化:股东陈文义于2026年3月17日至2026年6月22日合计减持142.79万股,占总股本0.2464%,持股比例由5.56%降至5.00%。本次权益变动后,陈文义持有公司股份28,969,486股,占总股本的5.00%,全部处于质押及冻结状态。未来12个月内,陈文义不排除继续减持或增持股份的可能,将依据法院执行情况及法规要求履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300000899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073954","title":"圣湘生物(688289)披露持股5%以上股东权益变动触及5%刻度的提示性公告,6月22日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645073954?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:29","pubTimestamp":1782138556,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘,圣湘生物报收于13.88元,较前一交易日下跌1.35%,最新总市值为80.42亿元。近日,圣湘生物科技股份有限公司发布《关于持股5%以上股东权益变动触及5%刻度的提示性公告》。权益变动后,其持股比例由5.56%降至5.00%。本次变动主要由于公司实施资本公积转增股本、股份注销及法院减持所致。权益变动未导致公司控股股东、实际控制人变化,不触及要约收购。相关信息已编制简式权益变动报告书并披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200038966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644906523","title":"每周股票复盘:圣湘生物(688289)股东陈文义持股被司法强制执行","url":"https://stock-news.laohu8.com/highlight/detail?id=2644906523","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644906523?lang=zh_cn&edition=full","pubTime":"2026-06-20 03:09","pubTimestamp":1781896190,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,圣湘生物报收于14.33元,较上周的14.36元下跌0.21%。公司公告汇总圣湘生物科技股份有限公司于2026年6月19日发布公告,持股5%以上股东陈文义因债务纠纷,其持有的2,519,984股公司股份已被司法强制执行,占公司总股本的0.44%。本次执行后,陈文义持股由32,917,370股减少至30,397,386股,持股比例由5.68%降至5.25%。公司同时收到法院通知,陈文义所持397万股公司股份拟被再次司法强制执行,执行方式包括大宗交易或集中竞价,执行期限不晚于2027年12月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062000001873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084265","title":"圣湘生物(688289)披露持股5%以上股东部分股份被司法强制执行的实施结果暨拟被再次司法强制执行的提示性公告,6月18日股价上涨0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084265","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644084265?lang=zh_cn&edition=full","pubTime":"2026-06-18 22:48","pubTimestamp":1781794097,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘,圣湘生物报收于14.33元,较前一交易日上涨0.99%,最新总市值为83.03亿元。公告显示,持股5%以上股东陈文义因债务纠纷,其持有的2,519,984股公司股份已被司法强制执行,占公司总股本的0.44%。本次执行后,陈文义持股由32,917,370股减少至30,397,386股,持股比例由5.68%降至5.25%。公司同时收到法院通知,陈文义所持397万股公司股份拟被再次司法强制执行,执行方式包括大宗交易或集中竞价,执行期限不晚于2027年12月30日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800042951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644760779","title":"股市必读:圣湘生物(688289)6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644760779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644760779?lang=zh_cn&edition=full","pubTime":"2026-06-17 04:32","pubTimestamp":1781641932,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘,圣湘生物报收于14.32元,下跌0.42%,换手率0.52%,成交量3.01万手,成交额4289.74万元。董秘最新回复投资者: 董秘您好:今年以来,公司陆续推出系列并购及股份注销、回购等举措,但公司股价却持续下跌,请问公司生产经营情况是否正常开展?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700003775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641127271","title":"每周股票复盘:圣湘生物(688289)调整利润分配现金分红总额","url":"https://stock-news.laohu8.com/highlight/detail?id=2641127271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641127271?lang=zh_cn&edition=full","pubTime":"2026-06-07 03:03","pubTimestamp":1780772590,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,圣湘生物报收于15.4元,较上周的16.39元下跌6.04%。本周,圣湘生物6月1日盘中最高价报16.72元。公司公告汇总圣湘生物科技股份有限公司维持每10股派发现金红利2.61元(含税)不变,因完成2023年限制性股票激励计划第二个归属期归属登记,归属股份75,000股,导致回购专用证券账户中股份数由4,525,202股减少至4,450,202股,实际参与分配的股份数相应调整为574,937,804股,现金分红总额由150,039,191.84元(含税)调整为150,058,766.84元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640515230","title":"圣湘生物最新公告:拟与关联方共同增资圣微速敏","url":"https://stock-news.laohu8.com/highlight/detail?id=2640515230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640515230?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:40","pubTimestamp":1780573243,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司拟与关联方圣湘金芙蓉基金等共同增资湖南圣微速敏生物科技有限公司,其中公司出资3500万元,认购新增注册资本3181.8182万元。交易完成后,公司将持有圣微速敏39.74%股权。本次交易构成关联交易,不构成重大资产重组,已获董事会审议通过,无需提交股东会审议。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400036933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640302152","title":"圣湘生物最新公告:董事长戴立忠提议以5000万元-1亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640302152","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640302152?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:39","pubTimestamp":1780573198,"startTime":"0","endTime":"0","summary":"圣湘生物(688289.SH)公告称,公司实际控制人兼董事长戴立忠提议公司以集中竞价交易方式回购股份,回购资金总额不低于5000万元(含),不超过1亿元(含),用于员工持股计划或股权激励。同时,提议将存放于回购专用证券账户中原用于员工持股计划或股权激励的445.02万股全部予以注销以减少注册资本,以提升每股收益水平,增强投资者信心。上述事项需经董事会及股东会审议,尚存在不确定性。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400036934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950698","title":"圣湘生物(688289)披露2023年限制性股票激励计划第二个归属期归属结果公告,6月1日股价上涨0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950698","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640950698?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:24","pubTimestamp":1780323868,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,圣湘生物报收于16.55元,较前一交易日上涨0.98%,最新总市值为95.89亿元。近日,圣湘生物科技股份有限公司发布《关于2023年限制性股票激励计划第二个归属期归属结果公告》。公告显示,公司已完成2023年限制性股票激励计划第二个归属期的股份登记工作,本次归属股票数量为75,000股,来源于公司从二级市场回购的A股普通股股票。本次归属不导致公司总股本及控股股东持股比例变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375568","title":"每周股票复盘:圣湘生物(688289)2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375568","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375568?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:30","pubTimestamp":1779564634,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘,圣湘生物报收于17.41元,较上周的17.45元下跌0.23%。本周,圣湘生物5月21日盘中最高价报17.8元。本周关注点来自公司公告汇总:圣湘生物2025年年度股东会审议通过利润分配、董事薪酬、审计机构聘任等多项议案。公司公告汇总圣湘生物科技股份有限公司于2026年5月20日召开2025年年度股东会,会议以现场与网络投票方式举行。所有议案均获通过,无被否决议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636251258","title":"圣湘生物(688289)披露2025年年度股东会法律意见书,5月20日股价上涨0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636251258","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636251258?lang=zh_cn&edition=full","pubTime":"2026-05-20 22:40","pubTimestamp":1779288034,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,圣湘生物报收于17.74元,较前一交易日上涨0.97%,最新总市值为102.78亿元。近日,圣湘生物披露湖南启元律师事务所出具的《关于圣湘生物科技股份有限公司2025年年度股东会的法律意见书》。湖南启元律师事务所对会议的召集和召开程序、出席会议人员资格、召集人资格、表决程序及表决结果等事项进行了见证,并确认各项议案均获有效表决通过,表决结果合法有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000043523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635072772","title":"圣湘生物(688289)披露2025年年度股东会会议资料,5月13日股价下跌0.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635072772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635072772?lang=zh_cn&edition=full","pubTime":"2026-05-13 17:38","pubTimestamp":1778665081,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘,圣湘生物报收于18.08元,较前一交易日下跌0.93%,最新总市值为104.75亿元。该股当日开盘18.13元,最高18.29元,最低17.9元,成交额达1.22亿元,换手率为1.16%。圣湘生物科技股份有限公司于近日披露《2025年年度股东会会议资料》。公告显示,2025年,圣湘生物实现营业收入16.42亿元,同比增长12.58%;归属于上市公司股东的净利润为1.99亿元,同比下降17.52%。董事会全年召开13次会议,审议55项议案,召集5次股东大会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300032575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688289"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634409989","title":"圣湘生物涨5.19%,华源证券二日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634409989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634409989?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:30","pubTimestamp":1778488250,"startTime":"0","endTime":"0","summary":"今日圣湘生物涨5.19%,收盘报19.06元。2026年5月9日,华源证券研究员刘闯,林海霖发布了对圣湘生物的研报《一体机推广顺利,医疗生态圈建设加码》,该研报对圣湘生物给出“买入”评级。基于公司分子产品布局完成,呼吸道产品渗透率不断提升,维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为26.26%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为华鑫证券的胡博新。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100021928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688289","161027"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782872751535,"stockEarnings":[{"period":"1week","weight":0.0162},{"period":"1month","weight":-0.1053},{"period":"3month","weight":-0.2056},{"period":"6month","weight":-0.2245},{"period":"1year","weight":-0.2746},{"period":"ytd","weight":-0.2245}],"compareEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0369},{"period":"6month","weight":0.0316},{"period":"1year","weight":0.1887},{"period":"ytd","weight":0.0316}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"圣湘生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21493人(较上一季度增加7.68%)","perCapita":"26957股","listingDate":"2020-08-28","address":"湖南省长沙市岳麓区高新技术产业开发区麓松路680号","registeredCapital":"57938万元","survey":" 圣湘生物科技股份有限公司的主营业务是诊断试剂和仪器的研发、生产、销售,以及第三方医学检验服务。公司的主要产品是诊断试剂、诊断仪器、生物类药品、检测服务。公司是国家基因检测技术应用示范中心、感染性疾病及肿瘤基因诊断技术国家地方联合工程研究中心、国家企业技术中心、国家技术创新示范企业、国家级博士后科研工作站单位、国家知识产权示范企业,荣获国家科技进步二等奖、中国专利银奖等60余项国内外重大奖项,承担国家“十三五”“十四五”等重大项目60余项。","listedPrice":50.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣湘生物,688289,圣湘生物股票,圣湘生物股票老虎,圣湘生物股票老虎国际,圣湘生物行情,圣湘生物股票行情,圣湘生物股价,圣湘生物股市,圣湘生物股票价格,圣湘生物股票交易,圣湘生物股票购买,圣湘生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣湘生物(688289)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣湘生物(688289)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}